Browsing by Author Yip, Sonia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2015EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma.Espinoza, David; Hudson, Amanda; Long, Anne; Martin, Andrew; Pavlakis, Nick; Stockler, Martin; Thompson, John; Yip, Sonia; Azad, A; Davis, I D; Goldstein, David; Harrision, M; Harvie, R; Jovanovic, L; Kannourakis, G; Kichenadasse, G; Lowenthal, Raymond M.; Nelson, C C; Shapiro, J; Steer, C; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; NH&MRC Clinical Trials CentreEVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma., Annals of Oncology, vol.26, 6, 2015,pp 1118-1123
2015Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialChin, Venessa; Gill, Anthony; Grimison, Peter; Nagrial, Adnan; Pavlakis, Nick; Samra, Jaswinder; Sebastian, Lucille; Simes, Robert John; Sjoquist, Katrin; Yip, Sonia; Asghari, R; Biankin, Andrew; Brown, Belinda; Chang, David; Chantrill, Lorraine; Chou, Angela; Grimmond, Sean; Harvey, Sandra L; Humphris, Jeremy; Johns, Amber L; Jones, Mark D; Martyn-Smith, Mona; Mead, Scott; Morey, Adrienne; Pajic, Marina; Simpson, Skye H; Thomas, David; Watson, Clare; Watson, Nicole; Central Clinical School: Medicine; Northern Clinical School: Pathology; NH&MRC Clinical Trials Centre; Medicine; Northern Clinical School: Medicine; Northern Clinical School: Surgery; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePrecision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial, Clinical Cancer Research, vol.21, 9, 2015,pp 2029-2037
2016Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II TrialMartin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Tsobanis, Eric; Wong, Ka (Mark); Yip, Sonia; Alcindor, Thierry; bang, Yungjue; Burnell, Margot J; Cho, Jaeyong; Goldstein, David; Kang, Yoon-Koo; Kim, Jinwon; Lee, Jeeyun; Lipton, Lara; O'Callaghan, Chris; Rha, Sunyoung; Strickland, A. H.; Tebbutt, Niall; Zalcberg, John; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreRegorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial, Journal of Clinical Oncology, vol.34, 23, 2016,pp 2728-2735
2011Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysisBoland, Amy L.; Brown, Christopher; Clarke, Stephen; Gebski, Val; Simes, Robert John; Yip, Sonia; Buck, M; Goldstein, David; Jeffrey, G. Mark; Lowenthal, Raymond M.; Ransom, David T.; Tebbutt, Niall C; van Hazel, Guy; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSingle-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis, European Journal of Cancer, vol.47, 12, 2011,pp 1826-1836